Beximco Pharmaceuticals Limited Current Assets

Beximco Pharmaceuticals Limited posts a current assets of $28B as of March 2026. That compares with $25B in the prior-year period — up 10.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Beximco Pharmaceuticals Limited's current assets was $25B. The latest reading is $28B — a 10.3% year-over-year increase (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Beximco Pharmaceuticals Limited's financial statement story. At $28B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BXP.L's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Beximco Pharmaceuticals Limited's other metric pages and overview cover the third.